Mulai Yohannes, MD
Pulmonary Disease · Lanham, MDNPI 1942217781
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pulmonary disease clinicians in MD, where the typical reported total is $830.
Across 32 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$138
- Mylan Specialty L.p.$78
- Exact Sciences$65
- Bayer$61
- GSK$59
- Harmony Biosciences LLC$49
- plus $247 from 9 others
What the payments were for
- Food & beverage$697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 6 | $138 |
| Mylan Specialty L.p. | 3 | $78 |
| Exact Sciences | 2 | $65 |
| Bayer | 3 | $61 |
| GSK | 3 | $59 |
| Harmony Biosciences LLC | 2 | $49 |
| Viatris Specialty LLC | 3 | $46 |
| Pfizer | 2 | $42 |
| Resmed Corp | 2 | $33 |
| Almatica Pharma LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Global Blood Therapeutics, Inc. | 1 | $21 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| CSL Behring | 1 | $19 |
| Novo Nordisk | 1 | $18 |
How this compares
$697 in reported general payments places this provider in the 45th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Lanham
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Lonny YarmusBaltimore$582K
- Robert WiseBaltimore$389K
- da Wei LiaoBethesda$310K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.